U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease (Q37074253)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 January 2008

Language	Label	Description	Also known as
English	U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease	scientific article published on 30 January 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

author name string

J J Scarisbrick

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

P Taylor

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

U Holtick

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Y Makar

4

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

K Douglas

5

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

G Berlin

6

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

E Juvonen

7

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

S Marshall

8

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Photopheresis Expert Group

9

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

language of work or name

0 references

publication date

30 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

158

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

659-678

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Photopheresis: clinical applications and mechanism of action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Prognostic Factors in Erythrodermic Mycosis Fungoides and the Sézary Syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Long-term extracorporeal photoimmunotherapy for treatment of chronic cutaneous graft-versus-host disease: observations in four patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Chronic graft-versus-host disease: where do we go from here?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

How I treat chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy--the Columbia Presbyterian experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Photopheresis therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Circulating CD4+CD7− Lymphocyte Burden and Rapidity of Response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy (ECP) in treatment of patients with c-GVHD and CTCL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2007.08415.X

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37074253&oldid=2236751124"